drug · antibody

etigilimab

Phase 2updated 3mo ago

by $MREO Mereo BioPharma Group plc🔗 ChEMBL

Phase 2

community read0 votes

Antibody drug with a maximum clinical stage of Phase 1 2, with 1 investigational indication.

targets

T-cell immunoreceptor with Ig and ITIM domains

all catalysts(0)

nothing on the calendar yet

Trials studying etigilimab

phase2EON: A Single-arm Phase II Study of Etigilimab (OMP-313M32) in Combination With Checkpoint Inhibition (Nivolumab) in Patients With Platinum-resistant, Recurrent Epithelial Ovarian Canceractive not recruitingn=20
phase2A Study of Etigilimab and Nivolumab in Participants With Locally Advanced or Metastatic Tumorscompletedn=76

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov · OpenTargets

last refreshed 5m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

drug · antibody

save

etigilimab

Phase 2updated 3mo ago

by $MREO Mereo BioPharma Group plc🔗 ChEMBL

Phase 2

community read0 votes

Antibody drug with a maximum clinical stage of Phase 1 2, with 1 investigational indication.

targets

T-cell immunoreceptor with Ig and ITIM domains

all catalysts(0)

nothing on the calendar yet

Trials studying etigilimab

phase2EON: A Single-arm Phase II Study of Etigilimab (OMP-313M32) in Combination With Checkpoint Inhibition (Nivolumab) in Patients With Platinum-resistant, Recurrent Epithelial Ovarian Canceractive not recruitingn=20
phase2A Study of Etigilimab and Nivolumab in Participants With Locally Advanced or Metastatic Tumorscompletedn=76

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov · OpenTargets

last refreshed 5m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

etigilimab

targets

all catalysts(0)

Trials studying etigilimab

News(0)

Report a data issue

comments(0)

etigilimab

targets

all catalysts(0)

Trials studying etigilimab

News(0)

Report a data issue

comments(0)